advertisement

Topcon

Rowe-Rendleman CL 1

Showing records 1 to 1 | Display all abstracts from Rowe-Rendleman CL

69793 Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study
Harris A; Ward CL; Rowe-Rendleman CL; Ouchi T; Wood A; Fujii A; Serle JB
Journal of Glaucoma 2016; 25: e826-e833

Issue 18-2

Change Issue


advertisement

Oculus